Abstract
The syndrome of hemiparkinsonism-hemiatrophy is an uncommon form of secondary Parkinsonism that presents with unilateral body Parkinsonism plus variable atrophy on the same side. Diagnosis of this syndrome needs a complete past medical history taking, as well as assessment of the familial history, clinical examination and complete paraclinical tests.The response to medical therapy has been variable in various researches. This case showed a good response to the addition of a dopamine agonist to levodopa therapy.
MeSH terms
-
Adult
-
Antiparkinson Agents / therapeutic use
-
Atrophy / complications
-
Benzothiazoles / therapeutic use
-
Biperiden / therapeutic use
-
Carbidopa / therapeutic use*
-
Cerebral Cortex / diagnostic imaging
-
Cerebral Cortex / pathology*
-
Cerebral Ventricles / pathology
-
Dopamine Agonists / therapeutic use
-
Drug Combinations
-
Humans
-
Indans / therapeutic use
-
Levodopa / therapeutic use*
-
Magnetic Resonance Imaging
-
Male
-
Monoamine Oxidase Inhibitors / therapeutic use
-
Parkinson Disease, Secondary / complications*
-
Parkinson Disease, Secondary / drug therapy*
-
Pramipexole
-
Tomography, X-Ray Computed
Substances
-
Antiparkinson Agents
-
Benzothiazoles
-
Dopamine Agonists
-
Drug Combinations
-
Indans
-
Monoamine Oxidase Inhibitors
-
carbidopa, levodopa drug combination
-
rasagiline
-
Biperiden
-
Levodopa
-
Pramipexole
-
Carbidopa